Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04547361 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess the Safety and Tolerability of E2511 in Healthy Participants
A Phase 1 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 1
- Development phase
- 45
- Enrollment target
NCT04547361 is a Phase 1 study that has completed, run by Eisai. The registered enrollment target is 45 participants.
The verdict
NCT04547361, a Phase 1 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 45 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the safety, tolerability, and pharmacokinetic (PK) of E2511 following single ascending oral doses in healthy adult and elderly participants.
Interventions
- DRUG E2511
- DRUG E2511 Matched Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2020-09-14 |
| Est. Completion | 2021-05-26 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04547361
The ClinicalTrials.gov registry entry for NCT04547361 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which E2511 is the first listed.
NCT04547361 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04547361 about?
NCT04547361 is a clinical study titled "A Study to Assess the Safety and Tolerability of E2511 in Healthy Participants". The primary objective of this study is to evaluate the safety, tolerability, and pharmacokinetic (PK) of E2511 following single ascending oral doses in healthy adult and elderly participants.
What is the current status of trial NCT04547361?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 2020-09-14. Estimated completion is 2021-05-26.
What interventions are being tested in trial NCT04547361?
The interventions under investigation include: E2511 (DRUG), E2511 Matched Placebo (DRUG).
Who is sponsoring clinical trial NCT04547361?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.